Document is current

Article History

Received: 26 November 2024

Accepted: 16 January 2026

First Online: 31 January 2026

Declarations

:

: The IMPROVEjob trial, conducted in North Rhine-Westphalia, Germany, involved personnel from general practice (GP) offices who were randomized into an intervention group or a waiting-list control group. The study aimed to evaluate the effectiveness of the IMPROVEjob intervention in improving job satisfaction, measured by the German version of the COPSOQ 2018. Baseline data were collected immediately before the start of the nine-month intervention, with follow-up data collected at the end of the intervention period.The study complies with the ethical principles of the World Medical Association Declaration of Helsinki. The trial was approved by the Ethics Committee of the Medical Faculty of the University of Bonn (reference number 057/19, 20 February 2019), as well as by the Ethics Committee of the Medical Association North-Rhine (Lfd-Nr.: 2019107) and the Ethics Committee of the Medical Faculty, University Hospital of Tuebingen (Project-No.: 446/2019BO2). All participants provided written informed consent prior to participation. German Clinical Trials Register: DRKS00012677. Registered on 16 October 2019. Retrospectively .

: All participating practice team members received written information and signed informed consent forms are stored at the Institute for General Practice and Family Medicine, University of Bonn.

: The authors declare no competing interests.